scholarly article | Q13442814 |
P50 | author | Dan J. Stein | Q5213742 |
Ronald C. Kessler | Q7364712 | ||
Hans-Ulrich Wittchen | Q1435357 | ||
Ayelet Meron Ruscio | Q87018871 | ||
Peter Roy-Byrne | Q98918613 | ||
P2093 | author name string | Wai Tat Chiu | |
Paul E Stang | |||
P2860 | cites work | Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication | Q22253031 |
Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication | Q22253034 | ||
Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey | Q28258215 | ||
Deconstructing current comorbidity: data from the Australian National Survey of Mental Health and Well-Being | Q30734969 | ||
Generalized anxiety disorder in women. A population-based twin study | Q33983606 | ||
What is generalized anxiety disorder? | Q34287208 | ||
The National Comorbidity Survey Replication (NCS-R): background and aims. | Q34339246 | ||
The US National Comorbidity Survey Replication (NCS-R): design and field procedures. | Q34339251 | ||
Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey | Q34402298 | ||
Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions | Q34456401 | ||
Patterns and correlates of generalized anxiety disorder in community samples. | Q34666287 | ||
Should excessive worry be required for a diagnosis of generalized anxiety disorder? Results from the US National Comorbidity Survey Replication | Q35850057 | ||
The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI) | Q39605659 | ||
Maintenance treatment studies in anxiety disorders: some methodological notes | Q40483228 | ||
Reliability and validity studies of the WHO--Composite International Diagnostic Interview (CIDI): a critical review | Q40691529 | ||
The empirical basis of generalized anxiety disorder | Q40692918 | ||
Toward a definition of generalized anxiety disorder as an anxious temperament type. | Q43993275 | ||
Generalized anxiety disorder and its comorbidities: disputes at the boundaries. | Q44108550 | ||
Generalized anxiety disorder (ICD-10) in primary care from a cross-cultural perspective: a valid diagnostic entity? | Q47685843 | ||
Evaluation of the ratings comprising the associated symptom criterion of DSM-III-R generalized anxiety disorder. | Q48859393 | ||
Generalized anxiety and generalized anxiety disorder: description and reconceptualization. | Q51214231 | ||
Rethinking the duration requirement for generalized anxiety disorder: evidence from the National Comorbidity Survey Replication. | Q51927655 | ||
Generalized anxiety and depression in primary care: prevalence, recognition, and management. | Q51956443 | ||
The concept of generalized anxiety disorder: between the too narrow and too wide diagnostic criteria. | Q51988195 | ||
Empirical evaluation of DSM-IV generalized anxiety disorder criteria in children and adolescents. | Q51997347 | ||
DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. | Q52026391 | ||
DSM-III generalized anxiety disorder: an empirical investigation of more stringent criteria. | Q52082584 | ||
DSM-IV generalized anxiety disorder in the Australian National Survey of Mental Health and Well-Being. | Q53313144 | ||
One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample | Q57384158 | ||
Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia | Q60633583 | ||
The frequency and severity of generalized anxiety disorder symptoms. Toward a less cumbersome conceptualization | Q72774114 | ||
Reliability of DSM-IV anxiety and mood disorders: implications for the classification of emotional disorders | Q73651900 | ||
Characterizing generalized anxiety: temporal and symptomatic thresholds | Q74147513 | ||
DSM-IV and beyond: what is generalized anxiety disorder? | Q77427279 | ||
Depression and generalized anxiety disorder: co-occurrence and longitudinal patterns in elderly patients | Q81281125 | ||
P433 | issue | 5 | |
P921 | main subject | generalized anxiety disorder | Q845224 |
comorbidity | Q1414874 | ||
P304 | page(s) | 662-676 | |
P577 | publication date | 2006-11-21 | |
P1433 | published in | Journal of Anxiety Disorders | Q15758849 |
P1476 | title | Broadening the definition of generalized anxiety disorder: effects on prevalence and associations with other disorders in the National Comorbidity Survey Replication | |
P478 | volume | 21 |
Q42612663 | Adjunctive atomoxetine to SSRIs or SNRIs in the treatment of adult ADHD patients with comorbid partially responsive generalized anxiety (GA): an open-label study |
Q28083948 | Advancing understanding of executive function impairments and psychopathology: bridging the gap between clinical and cognitive approaches |
Q34480185 | Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM-V. |
Q34094552 | Anxiety disorders in older adults: a comprehensive review |
Q37216915 | Anxiety disorders in pregnancy |
Q44105598 | Anxious and non-anxious forms of major depression: familial, personality and symptom characteristics |
Q37155269 | Assessment of anxiety in older home care recipients |
Q36205791 | Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders. |
Q36414967 | Broadening of Generalized Anxiety Disorders Definition Does not Affect the Response to Psychiatric Care: Findings from the Observational ADAN Study |
Q36577463 | Characteristics of subjects with comorbidity of symptoms of generalized anxiety and major depressive disorders and the corresponding threshold and subthreshold conditions in an Arab general population sample. |
Q40788978 | Classification models for subthreshold generalized anxiety disorder in a college population: Implications for prevention. |
Q38905913 | Cross-sectional Comparison of the Epidemiology of DSM-5 Generalized Anxiety Disorder Across the Globe |
Q37378694 | Current considerations in the treatment of generalized anxiety disorder |
Q36776669 | Diagnostic overlap of generalized anxiety disorder and major depressive disorder in a primary care sample |
Q34722479 | Disability and health-related quality of life in outpatients with generalised anxiety disorder treated in psychiatric clinics: is there still room for improvement? |
Q37822308 | Efficacy and safety of silexan, a new, orally administered lavender oil preparation, in subthreshold anxiety disorder - evidence from clinical trials |
Q39312246 | Epidemiology of anxiety disorders: from surveys to nosology and back |
Q47252121 | Factor structure and construct validity of the Generalized Anxiety Disorder 7-item (GAD-7) among Portuguese college students |
Q34475300 | Generalized anxiety disorder and the proposed associated symptoms criterion change for DSM-5 in a treatment-seeking sample of anxious youth |
Q39973710 | Generalized anxiety disorder with and without excessive worry in Hong Kong |
Q39824550 | Generalized anxiety disorder: clinical presentation, diagnostic features, and guidelines for clinical practice |
Q37670715 | Generalized worry disorder: a review of DSM-IV generalized anxiety disorder and options for DSM-V. |
Q37216651 | Implications of modifying the duration requirement of generalized anxiety disorder in developed and developing countries |
Q34024109 | Management of generalized anxiety disorder in primary care: identifying the challenges and unmet needs |
Q26864049 | Profile of agomelatine and its potential in the treatment of generalized anxiety disorder |
Q42644398 | Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings. |
Q39706778 | Social Epidemiology of Depression and Anxiety by Gender Identity |
Q36876387 | Supplementary dimensional assessment in anxiety disorders. |
Q38640476 | The Effects of Resistance Exercise Training on Anxiety: A Meta-Analysis and Meta-Regression Analysis of Randomized Controlled Trials. |
Q36440925 | The Feasibility, Acceptability, and Efficacy of Delivering Internet-Based Self-Help and Guided Self-Help Interventions for Generalized Anxiety Disorder to Indian University Students: Design of a Randomized Controlled Trial |
Q34373287 | The WHO World Mental Health (WMH) Surveys. |
Q34575466 | The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys |
Q88958637 | The increase in interest in GAD: Commentary on Asmundson & Asmundson |
Q33721960 | The prevalence and burden of subthreshold generalized anxiety disorder: a systematic review |
Q48631412 | The spectrum of worry in the community-dwelling elderly |
Q45385710 | The status quo as a good outcome: How the DSM-5 diagnostic criteria for generalized anxiety disorder remained unchanged from the DSM-IV criteria |
Q33838692 | Threshold and subthreshold generalized anxiety disorder among US adolescents: prevalence, sociodemographic, and clinical characteristics |
Q37135528 | Worry and generalized anxiety disorder: a review and theoretical synthesis of evidence on nature, etiology, mechanisms, and treatment |
Q83049347 | [Influence of morbidity and the use of health resources in patients who require care for generalised anxiety disorder in the primary health care setting] |
Search more.